Amlodipine Besylate and Benazepril Hydrochloride
- Product NDC
- 70934-696
- 11-digit product format
- 709340696
- Labeler code
- 70934
- Product ID
- 70934-696_a9ee0ce0-c630-55e6-e053-2a95a90abe74
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Amlodipine Besylate and Benazepril Hydrochloride
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Denton Pharma, Inc. dba Northwind Pharmaceuticals
- Application
- ANDA077183
- Marketing category
- ANDA
- Marketing start
- 2020-05-08
- Marketing end
- 2023-12-31
- Substance
- AMLODIPINE BESYLATE; BENAZEPRIL HYDROCHLORIDE
- Active strength
- 10 mg/1; mg/1
- Pharmacologic classes
- Angiotensin Converting Enzyme Inhibitor [EPC], Angiotensin-converting Enzyme Inhibitors [MoA], Calcium Channel Antagonists [MoA], Calcium Channel Blocker [EPC], Cytochrome P450 3A Inhibitors [MoA], Decreased Blood Pressure [PE], Dihydropyridine Calcium Channel Blocker [EPC], Dihydropyridines [CS]
- NDC exclude flag
- No
- Listing certified through
- 0000-00-00
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70934-696-30 | 70934069630 | 30 CAPSULE in 1 BOTTLE, PLASTIC (70934-696-30) | 30 capsule | 2020-05-08 | 2023-12-31 | No | No | Current |